fatty acid amide hydrolase inhibitors (The Scripps Research Institute)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namefatty acid amide hydrolase inhibitors (The Scripps Research Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnandamide amidohydrolase inhibitors
TargetsAnandamide amidohydrolase
Therapy Area/IndicationsAnxiety DisordersPainSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersPainSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A